The global market of Abacavir Sulfate Active Pharmaceutical Ingredient (API) is managed by a relatively select number of dedicated manufacturers. Several companies across areas like China and the US hold significant shares in this vital segment of the pharmaceutical arena. Conformance is of the greatest importance, necessitating stringent regulator